Search

Your search keyword '"Levings, Megan K."' showing total 141 results

Search Constraints

Start Over You searched for: Author "Levings, Megan K." Remove constraint Author: "Levings, Megan K." Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
141 results on '"Levings, Megan K."'

Search Results

2. Tregs with an MHC class II peptide-specific chimeric antigen receptor prevent autoimmune diabetes in mice

3. SARS-CoV-2 Variants Omicron BA.4/5 and XBB.1.5 Significantly Escape T Cell Recognition in Solid-organ Transplant Recipients Vaccinated Against the Ancestral Strain

4. Preclinical assessment of antigen-specific chimeric antigen receptor regulatory T cells for use in solid organ transplantation

6. PHLPP Signaling in Immune Cells

7. Regulatory T Cell Biomarkers Identify Patients at Risk of Developing Acute Cellular Rejection in the First Year Following Heart Transplantation

10. Prevention of vascular-allograft rejection by protecting the endothelial glycocalyx with immunosuppressive polymers

12. 213.2: Preliminary Results of the First Clinical Trial to Prevent Graft Rejection in Heart Transplant Children Employing a Cellular Therapy With Autologous Treg Obtained From Thymic Tissue (thyTreg)

14. Adaptive immune responses to two-dose COVID-19 vaccine series in healthy Canadian adults ≥ 50 years: a prospective, observational cohort study.

15. 1165. Longitudinal Evaluation of SARS-CoV-2 Antibody Response Using Dried Blood Spot Samples Following Vaccination with Three and Four Doses of mRNA-1273, BNT162b2 and/or ChAdOx1-S in Adults Aged 50 and Above: Interim Analysis from the PREVENT-COVID Study

16. First-in-human therapy with Treg produced from thymic tissue (thyTreg) in a heart transplant infant

17. Dysregulated Immunity to Clostridioides difficile in IBD Patients Without a History of Recognized Infection

19. A germline heterozygous dominant negativeIKZF2variant causing syndromic primary immune regulatory disorder and ICHAD

20. 3D genomic features across >50 diverse cell types reveal insights into the genomic architecture of childhood obesity

21. Adaptive immune responses to two-dose COVID-19 vaccine series in healthy Canadian adults > 50 years: a prospective, observational cohort study

22. Insulin B peptide-MHC class II-specific chimeric antigen receptor-Tregs prevent autoimmune diabetes in mice

26. Sex biased human thymic architecture guides T cell development through spatially defined niches

27. Ustekinumab for type 1 diabetes in adolescents: a multicenter, double-blind, randomized phase 2 trial

28. Tonic-signaling chimeric antigen receptors drive human regulatory T cell exhaustion

32. Insulin B peptide-MHC class II-specific chimeric antigen receptor-Tregs prevent autoimmune diabetes

33. Human A2-CAR T cells reject HLA-A2+ human islets transplanted into mice without inducing graft versus host disease

34. Flagellin-specific human CAR Tregs for immune regulation in IBD

39. CD56brightCD16– natural killer cells as an important regulatory mechanism in chronic graft-versus-host disease

41. Preclinical assessment of antigen-specific chimeric antigen receptor regulatory T cells for use in solid organ transplantation

42. PTEN is required for human Treg suppression of costimulation in vitro

43. A Century-long Journey From the Discovery of Insulin to the Implantation of Stem Cell–derived Islets.

45. PTEN is required for human Treg suppression of costimulation

47. Guidelines for standardizing T-cell cytometry assays to link biomarkers, mechanisms, and disease outcomes in type 1 diabetes

48. Implanted pluripotent stem-cell-derived pancreatic endoderm cells secrete glucose-responsive C-peptide in patients with type 1 diabetes

49. Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)

50. A phase 1b open-label dose-finding study of ustekinumab in young adults with type 1 diabetes

Catalog

Books, media, physical & digital resources